Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6253)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 27, 2023 (publication date) through Apr 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fouad Y. Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate. World J Hepatol 2023; 15(2): 123-128 [PMID: 36926229 DOI: 10.4254/wjh.v15.i2.123] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i2/123.htm |
| Number | Citing Articles |
| 1 |
Wei Zhu, Eleonora Cremonini, Angela Mastaloudis, Patricia I. Oteiza. Glucoraphanin and sulforaphane mitigate TNFα-induced Caco-2 monolayers permeabilization and inflammation. Redox Biology 2024; 76: 103359 doi: 10.1016/j.redox.2024.103359
|
| 2 |
Yurina Akeno, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda. Metabolic dysfunction‐associated fatty liver disease and risks of incident coronary artery disease and cerebrovascular disease: LIFE Study. Hepatology Research 2025; doi: 10.1111/hepr.14185
|
| 3 |
Yasser Fouad, Mohamed Alboraie, Gamal Shiha. Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease. Hepatology International 2024; 18(S2): 827 doi: 10.1007/s12072-024-10704-3
|
| 4 |
Ruth Tulleners, Adrian Barnett, James O'Beirne, Elizabeth Powell, Ingrid J Hickman, Patricia C Valery, Sanjeewa Kularatna, Katherine Stuart, Carolyn McIvor, Elen Witness, Melanie Aikebuse, David Brain. Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD. BMJ Open Gastroenterology 2024; 11(1): e001418 doi: 10.1136/bmjgast-2024-001418
|
| 5 |
Anil C. Anand. MASLD, MLA Pesarattu and Other Developments. Journal of Clinical and Experimental Hepatology 2025; 15(1): 102465 doi: 10.1016/j.jceh.2024.102465
|
| 6 |
Giulia de Alteriis, Gabriella Pugliese, Antonella Di Sarno, Giovanna Muscogiuri, Luigi Barrea, Valentina Cossiga, Giuseppe Perruolo, Michele Francesco Di Tolla, Francesca Zumbolo, Pietro Formisano, Filomena Morisco, Silvia Savastano. Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage. International Journal of Molecular Sciences 2023; 24(13): 10885 doi: 10.3390/ijms241310885
|
| 7 |
Nso Nso, Damla Mergen, Mashaal Ikram, Victor Macrinici, Kifah Hussain, Kevin Lee, Derek Ugwendum, Mia Trimingham, Senthil Balasubramanian, Riya Sam, Basile Njei. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis. Current Problems in Cardiology 2024; 49(6): 102569 doi: 10.1016/j.cpcardiol.2024.102569
|
| 8 |
Joseph A. M. J. L. Janssen. Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes. International Journal of Molecular Sciences 2024; 25(10): 5488 doi: 10.3390/ijms25105488
|
| 9 |
Perry J. Pickhardt, Glen M. Blake, Yotam Kimmel, Esther Weinstock, Keren Shaanan, Shiri Hassid, Ahmad Abbas, Matthew A. Fox. Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool. American Journal of Roentgenology 2023; 221(6): 748 doi: 10.2214/AJR.23.29651
|
| 10 |
Yasser Fouad, Faisal Sanai, Mohamed Alboraie, Ming-Hua Zheng. What the New Definition of MASLD Left Behind: Dual Etiology With Viral Hepatitis. Clinical Gastroenterology and Hepatology 2024; 22(8): 1751 doi: 10.1016/j.cgh.2023.11.026
|
| 11 |
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, Dorota Łojko, Sebastian Kraszewski, Ali Ibrahim, Maria Hussey, Adam Deptuła, Żaneta Grzywacz, Alexandre Ternianov, David Unwin. Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD). Journal of Clinical Medicine 2024; 13(16): 4857 doi: 10.3390/jcm13164857
|
| 12 |
Yang Zhang, Qiangman Wei, Xue Geng, Guoliang Fang. Long-Term Aerobic Exercise Enhances Hepatoprotection in MAFLD by Modulating Exosomal miR-324 via ROCK1. Metabolites 2024; 14(12): 692 doi: 10.3390/metabo14120692
|
| 13 |
Saima Ajaz, Mark Chamley, James Lok, Riham Soliman, Reece Khan, Karan Ahir, Monique Curtis, María Fernanda Guerra-Veloz, Kosh Agarwal. Lack of awareness and ethnic polarity is a major cause of metabolic associated fatty liver disease in high-risk diabetes population in South London. Therapeutic Advances in Chronic Disease 2024; 15 doi: 10.1177/20406223241264539
|
| 14 |
Yuan Yao, Yunfeng Shen. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0699
|
| 15 |
Consolato M. Sergi. NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review. International Journal of Molecular Sciences 2024; 25(15): 8462 doi: 10.3390/ijms25158462
|
| 16 |
O.M. Radchenko, O.J. Komarytsia, M.O. Borovets, R.S. Ivasivka, R.R. Guta. Proinflammatory interleukins 2, 6 and tumor necrosis factor alpha in patients with hypertension and diabetes mellitus depending on the presence of metabolic-associated liver steatosis. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2024; 20(3): 200 doi: 10.22141/2224-0721.20.3.2024.1389
|
| 17 |
Anil Chandra Anand, Dibyalochan Praharaj. MASLD or MAFLD: fatty liver by any name will pose the same challenge. Metabolism and Target Organ Damage 2025; 5(2) doi: 10.20517/mtod.2025.18
|
| 18 |
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1291501
|
| 19 |
Ji Lee, Sue Kim, Yaeji Lee, Yu-Jin Kwon, Ji-Won Lee. Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis. Nutrients 2024; 16(20): 3551 doi: 10.3390/nu16203551
|